Juvenescence Competitors and Similar CompaniesClear all

Juvenescence's competitors and similar companies include Pharming Group, Macopharma, Abiogen Pharma and Immatics.
Juvenescence
Juvenescence
Juvenescence is a biotech longevity company that develops therapies and products targeting aging.
Pharming Group
Pharming Group
Pharming Group is a biopharmaceutical company developing protein replacement therapies and precision medicines for the treatment of rare diseases.
Macopharma
Macopharma
Macopharma is a provider of blood transfusion and bio-sourced therapies.
Abiogen Pharma
Abiogen Pharma
Abiogen Pharma is a specialist pharmaceutical company that focuses on bone metabolism and rare diseases.
Immatics
Immatics
Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer.
Founding Date
Founding Date
2016
Founding Date
1988
Founding Date
1977
Founding Date
1997
Founding Date
N/A
Type
Type
Private
Type
Public
Type
Private
Type
Subsidiary
Type
Public
Tags
Locations
Locations
Dublin, IE HQ
Locations
Leiden, NL HQ
Leiden, NL
Locations
Tourcoing, FR HQ
Mouvaux, FR
Locations
Pisa, IT HQ
Locations
Tübingen, DE HQ
Frankfurt Am Main, DE
München, DE
Houston, US
Employees
Employees
3310% increase
Employees
404
Employees
901
Employees
351
Employees
29723% increase
Valuation ($)
Valuation ($)
500 m
Valuation ($)
590.3 m
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
1.1 b

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$376.1m (FY, 2025)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
€48.3m (FY, 2025)
Cost of goods
Cost of goods
N/A
Cost of goods
$41.6m (FY, 2025)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
$341m (FY, 2025)
Gross profit
N/A
Gross profit
N/A
Gross profit
€53m (FY, 2025)
Net income
Net income
N/A
Net income
$2.5m (FY, 2025)
Net income
N/A
Net income
N/A
Net income
(€196.4m) (FY, 2025)

Funding

Total funding raised
Total funding raised
$ 162.3m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 267.3m
For sources of this data, please see the company profile

View Company Profiles

Pharming Group
HQ
Leiden, NL
Employees
404

Pharming Group is a biopharmaceutical company developing protein replacement therapies and precision medicines for the treatment of rare diseases.

View company
Macopharma
HQ
Tourcoing, FR
Employees
901

Macopharma is a provider of blood transfusion and bio-sourced therapies.

View company
Abiogen Pharma
HQ
Pisa, IT

Abiogen Pharma is a specialist pharmaceutical company that focuses on bone metabolism and rare diseases.

View company
Immatics
HQ
Tübingen, DE
Employees
297↑ 23% increase

Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer.

View company